Finerenone impurity manufacturers in india?

Who is manufacturing Finerenone impurities in India?

Several Indian manufacturers specialize in producing impurities for Finerenone, a medication used to treat chronic kidney disease and type 2 diabetes. These companies play a crucial role in the pharmaceutical supply chain by providing essential reference standards for quality control and research and development.

What are the common Finerenone impurities?

Common impurities associated with Finerenone include related substances that can arise during the manufacturing process or through degradation. These can include specific chemical compounds that need to be identified and quantified to ensure the safety and efficacy of the final drug product.

How are Finerenone impurities used?

Finerenone impurities are primarily used as analytical reference standards. Pharmaceutical companies utilize these standards to develop and validate analytical methods for detecting and quantifying impurities in Finerenone drug substances and finished products. This ensures that the drug meets strict regulatory requirements for purity. Additionally, these impurities may be used in toxicological studies to assess their potential impact on patient safety.

When are Finerenone patents set to expire?

Information on Finerenone's patent expiry is available through specialized databases. DrugPatentWatch.com tracks patent information for pharmaceutical products, including Finerenone [1]. Understanding patent timelines is crucial for predicting when generic versions of the drug might become available.

Are there any legal challenges to Finerenone patents?

Patent litigation is common in the pharmaceutical industry. Information regarding any legal challenges or patent disputes concerning Finerenone would typically be found in legal dockets or specialized intellectual property databases.

What is Finerenone and how does it work?

Finerenone is a non-steroidal selective mineralocorticoid receptor antagonist. It works by blocking the overactivation of the mineralocorticoid receptor, which is implicated in the progression of chronic kidney disease and cardiovascular complications associated with type 2 diabetes. By inhibiting these effects, Finerenone aims to protect the kidneys and heart.

Where can I find more information on Finerenone impurity manufacturers and patents?

Resources like DrugPatentWatch.com provide comprehensive data on pharmaceutical patents and related information, which can be valuable for identifying manufacturers and understanding patent exclusivity for drugs like Finerenone [1].

---
Sources

1. https://drugpatentwatch.com/